AIMD News and Press, Ainos Inc From 01/05/24

2024-01-05 10:07:14 ET DENVER, Colo., Jan. 5, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Banzai International Inc (NASDAQ: BNZI), Immunic Inc (NASDAQ: IMUX), Dermata Therapeutics (NASDAQ: DRMA), Aino...

2024-01-05 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

2024-01-05 09:40:51 ET DENVER, Colo., Jan. 5, 2024 ( www.247marketnews.com )- Ainos Inc (NASDAQ: AIMD) has a reported 4.68M shares outstanding and 751.1K shares in its float, so this morning’s premarket action is reason to keep this one on your trading screens. Ainos closed t...

2024-01-02 09:51:47 ET More on Ainos Financial information for Ainos For further details see: Ainos regains compliance with Nasdaq minimum bid price rule

SAN DIEGO, CA / ACCESSWIRE / January 2, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, announced tha...

Mass Production Readiness Targeted for 2H 2024 Propelling AI Nose Technology Towards Broader Industry Adoption and Advancing the Mission of Digitalizing Smell SAN DIEGO, CA / ACCESSWIRE / December 26, 2023 / Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified hea...

2023-12-12 10:14:16 ET More on Ainos Ainos to issue initial $3M tranche of $10M private placement of notes Financial information for Ainos For further details see: Ainos implements a reverse stock split

SAN DIEGO, CA / ACCESSWIRE / December 12, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos," or the "Company"), a diversified healthcare company focused on the development of AI-powered point-of-care testing, VELDONA® low-dose interferon therapeutics, and synthetic RNA-driven preventative ...

2023-12-08 17:38:23 ET More on Ainos Ainos to issue initial $3M tranche of $10M private placement of notes Financial information for Ainos For further details see: Ainos files to sell 10.2M shares of common stock for holders

Subsequent Phase Involves Completion of Chemistry, Manufacturing, and Controls (CMC) Information Ainos Intends to Submit Investigational New Drug Applications to the U.S. FDA for Multiple Candidates During the First Half of 2024 Candidates include HIV Oral Warts Orphan Drug, Sjogren's S...